Intrinsic Capacity and Functional Ability Monitoring With an Integrated Data Eco-System for Healthy Ageing. - Trial NCT06270979
Access comprehensive clinical trial information for NCT06270979 through Pure Global AI's free database. This phase not specified trial is sponsored by Prof. Ivan Bautmans and is currently Not yet recruiting. The study focuses on Frailty. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Prof. Ivan Bautmans
Vrije Universiteit Brussel
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 01, 2025
Primary Outcome
Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Experiences with ISHA (usability, feasibility and acceptability outcome)
Summary
In this study, 120 older adults (aged 65 years or older) either patients undergoing
 rehabilitation or older nursing home residents will be provided with an Eforto® device and
 the eco-System for Healthy Ageing (ISHA) mobile application to self-monitor intrinsic
 capacity for 4 months (if needed with assistance by an (in)formal caregiver). Preferably, the
 participants will use their own smartphone because mitigating smartphone-use-related issues.
 
 The aims of the study are:
 
 1. to evaluate the usability and feasibility of self-monitoring intrinsic capacity by using
 the ISHA system in rehabilitation and nursing home settings.
 
 2. to investigate if changes and variability in intrinsic capacity as measured with ISHA
 are related to changes in functional ability and quality of life.
 
 3. to explore individual trajectories of intrinsic capacity with the ISHA system.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06270979
Device Trial